Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MaxART: Early Access to ART for All in Swaziland

NCT02909218 is registered in ClinicalTrials.gov with Clinton Health Access Initiative Inc. as lead sponsor.

NCT NCT02909218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02909218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MaxART: Early Access to ART for All in Swaziland
Lead sponsor
Clinton Health Access Initiative Inc.
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2014
Completion date
August 31, 2017
Enrollment
3,485 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids